brand logo

Am Fam Physician. 2012;86(4):318

In the article “Prevention of Perinatal Group B Streptococcal Disease: Updated CDC Guideline” (July 1, 2012, page 59), the third to last sentence of the abstract (page 59) incorrectly stated that clindamycin is recommended in persons at serious risk of anaphylaxis if susceptibility is unknown. However, vancomycin, not clindamycin, is recommended in these persons. The sentence should have read: “For those at serious risk of anaphylaxis, clindamycin is recommended if the organism is susceptible, and vancomycin is recommended if there is clindamycin resistance or if susceptibility is unknown.” The online version of this article has been corrected.

Continue Reading

More in AFP

Copyright © 2012 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.